医学部 脳神経外科学

田邉 淳

タナベ ジュン  (tanabe jun)

基本情報

所属
藤田医科大学ばんたね病院 脳神経外科 講師

ORCID ID
 https://orcid.org/0000-0002-5015-8573
J-GLOBAL ID
201801021281827540
researchmap会員ID
7000023667

論文

 33
  • Kiyonori Kuwahara, Ichiro Nakahara, Shoji Matsumoto, Yoshio Suyama, Jun Morioka, Akiko Hasebe, Jun Tanabe, Sadayoshi Watanabe, Kenichiro Suyama, Yuichi Hirose
    Radiology case reports 19(5) 1692-1696 2024年5月  
    It is impossible to predict underlying anomalies in acute large vessel occlusion and it could be a problem when performing mechanical thrombectomy (MT). We report a case of MT for occlusion of the fenestrated middle cerebral artery (MCA) M1 segment. A 49-year-old woman presented to our hospital with dysarthria and left hemiparesis. Acute ischemic stroke due to right occluded MCA was diagnosed. During performing emergent MT, a part of the M1 segment was revealed to be slit-shaped by digital subtraction angiography, suggesting a fenestrated MCA. The aspiration catheter could not be advanced through the narrow limb of the fenestration, and the distal thrombus was retrieved using a stent retriever, additionally. Postoperatively, the patient's symptoms improved without complications. When occlusion of the fenestrated MCA is suspected, it is necessary to consider converting the strategy from an aspiration catheter alone to the combined use of a stent retriever.
  • Kenichiro Suyama, Ichiro Nakahara, Shoji Matsumoto, Jun Morioka, Jun Tanabe, Akiko Hasebe, Sadayoshi Watanabe
    Clinical neuroradiology 34(1) 201-208 2024年3月  
    PURPOSE: Prasugrel is not approved for patients treated with flow diverters, which have a high metal coverage ratio. However, robust antiplatelet therapy with prasugrel may prevent thromboembolic complications. We administered prasugrel and aspirin to all patients treated with flow diverters and reported the safety of the antiplatelet therapy regimen. METHODS: This retrospective, single-center study evaluated the angiographic and clinical data of consecutive patients treated with flow diverters for cerebral unruptured aneurysms between June 2020 and May 2022. All patients received dual antiplatelet therapy, including prasugrel and aspirin. The administration of prasugrel ended 3 or 6 months after the procedure, whereas aspirin use continued for at least 12 months. Periprocedural complications (< 30 days post-procedure) and delayed complications (> 30 days post-procedure) were recorded. RESULTS: During the study period, 120 unruptured aneurysms were treated with flow diverters in 110 patients. All patients, except one, survived longer than 12 months after the procedure. The rate of thromboembolic complications was 6.4%, and more than half of the patients had transient symptoms; one (0.9%) had a major ischemic stroke. One patient (0.9%) each had an asymptomatic, small subarachnoid hemorrhage and significant hemorrhagic complications with melena. The rate of permanent neurological deficits was 1.8%, and the mortality rate was 0.9%. CONCLUSIONS: Dual antiplatelet therapy comprising routine use of prasugrel and aspirin for flow diverter-implanted patients possibly contributed to a low rate of thromboembolic complications and low risk of hemorrhagic complications.
  • Kiyonori KUWAHARA, Ichiro NAKAHARA, Shoji MATSUMOTO, Yoshio SUYAMA, Jun MORIOKA, Akiko HASEBE, Jun TANABE, Sadayoshi WATANABE, Kenichiro SUYAMA, Yuichi HIROSE
    Surgery for Cerebral Stroke 52(3) 210-217 2024年  
  • Yoshio Suyama, Ichiro Nakahara, Akiko Hasebe, Shoji Matsumoto, Jun Morioka, Tetsuya Hashimoto, Jun Tanabe, Sadayoshi Watanabe, Kenichiro Suyama
    Interdisciplinary Neurosurgery 2023年12月  
  • Jun Tanabe, Ichiro Nakahara, Takuma Ishihara, Shoji Matsumoto, Jun Morioka, Akiko Hasebe, Sadayoshi Watanabe, Kenichiro Suyama
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 114 55-61 2023年6月10日  査読有り
    PURPOSE: Optimal size selection is important for successful Woven EndoBridge (WEB) treatment. Conventional recommendations for WEB sizing based on aneurysm width and height sometimes require device exchange. We aimed to design a novel volume-based parameter, the ideal WEB-aneurysm volume (iWAVe) ratio, for optimal WEB sizing. METHODS: Consecutive patients who underwent WEB treatment for wide-neck bifurcation aneurysms between January 2021 and May 2022 were retrospectively reviewed. Aneurysm volume was automatically calculated using software. We measured the aneurysm volume based on the expected position of the device within the aneurysm. The WAVe ratio was defined as the ratio of the aneurysm volume to WEB volume. We dichotomized aneurysms treated with a successful sizing or unsuccessful sizing for WEB (successful group and unsuccessful group, respectively). RESULTS: Thirty-five patients were eligible for study enrollment. Ten patients (28.6%) needed to exchange the WEB on the first attempt and required another WEB on the second attempt resulting in deployment success. Hence, 35 aneurysms were in the successful group and 10 were in the unsuccessful group. The median WAVe ratio was 1.0 (range 0.76-1.31) in the successful group and 1.27 (0.58-1.89) in the unsuccessful group. Using logistic regression, iWAVe ratio was from 0.90-1.16 to secure a >80% probability of success by the 95% lower confidence limit. The sensitivity and specificity of the iWAVe ratio for optimal size selection on the first attempt were 0.60 and 1.00, respectively. CONCLUSION: Decision-making based on aneurysm width and the iWAVe ratio could promote optimal WEB sizing.

MISC

 84

書籍等出版物

 1